<SEC-DOCUMENT>0001104659-23-088339-index.html : 20230807 <SEC-HEADER>0001104659-23-088339.hdr.sgml : 20230807 <ACCEPTANCE-DATETIME>20230807160755 ACCESSION NUMBER: 0001104659-23-088339 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20230807 DATE AS OF CHANGE: 20230807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 231147667 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>DEFA14A <SEQUENCE>1 <FILENAME>tm2320944d2_defa14a.htm <DESCRIPTION>DEFA14A <TEXT> Document 1 - file: tm2320944d2_defa14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>tm2320944d2_defa14aimg001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: tm2320944d2_defa14aimg001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>tm2320944d2_defa14aimg002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: tm2320944d2_defa14aimg002.jpg
</DOCUMENT> </SEC-DOCUMENT>